[admin]

Hyperbaric oxygen is not one treatment — it is a dose range. Here is what physically changes in the body at each pressure, which indications carry real evidence, and where the line sits between a clinical chamber and a wellness cabin.

Primary search intent	How hyperbaric oxygen therapy works; what pressure is used; is it evidence-based
Suggested slug	/insights/how-hyperbaric-oxygen-therapy-works-ata-guide
Meta description	At 3 ATA, dissolved oxygen in plasma rises roughly twenty-fold. A pressure-by-pressure guide to HBOT mechanisms, evidence, protocols, safety and chamber specification.
Target keywords	hyperbaric oxygen therapy, HBOT, 1.3 ATA, mild hyperbaric oxygen therapy, hyperbaric oxygen chamber, plasma oxygen tension, angiogenesis, UHMS indications

 

Quick answer Hyperbaric oxygen therapy (HBOT) means breathing near-100% oxygen inside a chamber pressurised above sea level. At 3.0 ATA — the pressure at roughly 20 metres of seawater — oxygen dissolved in blood plasma rises from about 0.3 to 6 mL per 100 mL of blood, enough to sustain tissue without red blood cells. That single physical change produces every downstream effect: faster wound repair, shrinkage of gas bubbles, reduced swelling, new blood-vessel growth and tighter infection control. Pressures of 2.0–3.0 ATA are clinical doses used for 14 recognised indications; chambers limited to 1.1–1.3 ATA deliver mild HBOT, a wellness and recovery service that does not replace clinical treatment.

Key facts at a glance

● Pressure unit: ATA (atmospheres absolute) includes the 1 atm of air we already live in. 2.0 ATA equals 101 kPa gauge pressure, or 10 m of seawater.

● Oxygen carriage: at 1 ATA, plasma carries about 0.3 vol% oxygen; at 3 ATA, about 6 vol% — a twenty-fold increase in the dissolved fraction.

● Dose ranges: 1.1–1.3 ATA (mild HBOT), 2.0–2.5 ATA (routine clinical HBOT), 2.5–3.0 ATA (emergency indications).

● Session shape: 60–120 minutes at pressure, compression and decompression of 10–15 minutes each, typically 20–40 sessions per course.

● Absolute contraindication: untreated pneumothorax. Fire risk rises with any oxygen enrichment of the cabin atmosphere, which is why chamber design — not only pressure — determines safety.

1. The number that defines the therapy: ATA

Every claim about hyperbaric oxygen depends on the pressure at which it is delivered. ATA is an absolute scale: 1.0 ATA is the air pressure at sea level, and each additional atmosphere equals the pressure of another 10 metres of seawater. A chamber sold as “1.3 ATA” therefore raises pressure by only 30 kPa, while a hospital chamber running at 2.4 ATA nearly triples the ambient pressure.

Pressure	Gauge pressure	Sea-water equivalent	Typical application
1.0 ATA	0 kPa	Surface	Normal breathing, no therapy
1.3 ATA	30 kPa	3 m	Mild HBOT: recovery, wellness, sports
1.5 ATA	51 kPa	5 m	Upper end of mild HBOT; fatigue, altitude recovery
2.0 ATA	101 kPa	10 m	Clinical HBOT: most elective indications
2.4 ATA	142 kPa	14 m	Wound repair, radiation injury, flaps and grafts
3.0 ATA	203 kPa	20 m	Decompression sickness, gas gangrene, severe CO poisoning

2. Mechanism one: oxygen dissolves directly into plasma

Haemoglobin is a delivery system with a ceiling: at normal pressure it is about 97% saturated and cannot carry more. Pressure bypasses that ceiling. Because the amount of gas dissolved in a liquid is proportional to its partial pressure (Henry’s law), raising alveolar oxygen tension from roughly 100 mmHg at sea level to more than 1,800 mmHg at 3 ATA pushes oxygen directly into solution.

The classic demonstration came in 1960, when Dutch surgeon Ite Boerema replaced the blood of pigs with plasma and kept them alive at 3 ATA of oxygen — the experiment that gave HBOT its founding principle, “life without blood”. Clinically, the dissolved fraction matters less for survival than for reach: it perfuses tissue that red cells cannot reach because swelling, radiation scarring or blocked microvessels have stopped them.

3. Mechanism two: pressure physically shrinks gas bubbles

Boyle’s law states that the volume of a gas is inversely proportional to pressure. At 3 ATA a bubble retains one third of its volume at the surface, and its diameter falls by about 30%. For an arterial gas embolism or a bubble of nitrogen in decompression sickness, that reduction restores blood flow past the obstruction before any biochemical effect occurs — which is why these two emergencies are treated at 2.8–3.0 ATA without delay.

4. Mechanism three: vasoconstriction that does not starve tissue

Hyperoxia constricts arterioles and typically reduces regional blood flow by 10–20%. In ordinary circumstances that would be harmful. In hyperbaric conditions, plasma oxygen tension is high enough that tissue oxygenation still rises while blood flow and capillary leak fall — the combination that makes HBOT useful in crush injury, compartment syndrome, burns and compromised flaps, where oedema is the enemy.

5. Mechanism four: rebuilding the microcirculation

Repeated exposures trigger a repair programme rather than a single physiological spike. Reactive oxygen species act as signals that stabilise HIF-1 and up-regulate vascular endothelial growth factor; fibroblasts proliferate and lay down collagen; circulating progenitor cells mobilise. Studies of patients completing a course of 2.0 ATA sessions report several-fold increases in circulating CD34+ cells. This delayed, cumulative mechanism explains why wound and radiation-injury protocols run for 20–40 sessions rather than one.

6. Mechanism five: immune control at the infection site

Oxygen is a substrate for the neutrophil oxidative burst. In necrotising soft-tissue infection, refractory osteomyelitis and biofilm-associated wounds, raising tissue oxygen tension restores killing capacity that is otherwise switched off by hypoxia, and improves the penetration of many antibiotics. It is also why HBOT is used as an adjunct to surgery and antibiotics, never as a replacement for source control.

7. What the evidence actually supports

The Undersea and Hyperbaric Medical Society recognises fourteen indications, and most public health systems reimburse a subset of them. They divide into two practical groups:

Emergency and urgent (2.4–3.0 ATA)	Elective and reconstructive (2.0–2.5 ATA)
Arterial gas embolismDecompression sicknessCarbon monoxide poisoning and smoke inhalationClostridial myonecrosis (gas gangrene)Crush injury and compartment syndrome	Delayed radiation injury (soft tissue and bone)Compromised grafts and flapsRefractory osteomyelitisNecrotising soft-tissue infectionsDiabetic and problem wounds (selected)Acute thermal burnsSevere anaemia, intracranial abscess, sudden sensorineural hearing loss, central retinal artery occlusion

Beyond these, the picture is genuinely mixed. Long COVID, post-operative recovery, athletic performance, cognitive ageing and inflammatory bowel disease all have published trials, most of them small, single-centre or industry-funded. They are reasonable subjects for further study and poor subjects for absolute claims — a distinction worth keeping in any commercial copy you publish.

8. The line between clinical HBOT and mild HBOT

A 1.3 ATA cabin cannot reproduce the oxygen tension of a 2.4 ATA treatment: plasma oxygen at 1.3 ATA is roughly one third of the clinical dose. This is not a marketing detail, it is a physical fact, and it shapes how a chamber should be sold. Mild HBOT belongs in wellness centres, hotels and sports facilities as a recovery and comfort service, with honest wording about what it does. Clinical HBOT belongs in a medical facility, prescribed by a physician, delivered by trained operators, with records and adverse-event reporting.

Regulators increasingly police that boundary. In the United States the FDA clears chambers for specific indications and has issued warnings about unproven claims; in the EU, chambers fall under medical device rules when a medical claim is made. A supplier that helps you write compliant positioning is worth more than one that supplies superlatives.

9. What a session actually involves

Stage	Duration	What happens
Screening	10–15 min	Contraindication check, vital signs, ear examination, consent
Compression	10–15 min	Pressure rises; patients equalise ears by swallowing or the Valsalva manoeuvre
At pressure	60–90 min	Oxygen by mask or hood; rest, reading or monitoring; air breaks in clinical protocols
Decompression	10 min	Controlled ascent; final observations before discharge

10. Safety: the design features that matter more than the brochure

Hyperbaric oxygen carries three specific risks — barotrauma (mostly of the middle ear), oxygen toxicity (central nervous system and pulmonary), and fire. The third is the one that shapes engineering. A chamber must keep its internal atmosphere from becoming oxygen-enriched: LBYL specifies oxygen dispersion inside the cabin below 25%, with 93% ± 3% oxygen delivered through individual masks rather than flooding the cabin. Pressure protection is layered, with one manual and two automatic relief valves in single-seat units and an additional emergency relief valve; electrical systems follow IEC 60601-1 medical safety requirements.

Patient selection matters just as much. Untreated pneumothorax is an absolute contraindication. Relative cautions include claustrophobia, Eustachian tube dysfunction, uncontrolled seizure disorders, certain chemotherapy agents such as bleomycin and doxorubicin, fever, and pregnancy outside carbon monoxide poisoning. Any operator running a chamber without a written screening protocol is running a risk that no certificate will cover.

Frequently asked questions

Is a 1.3 ATA chamber the same as clinical hyperbaric oxygen therapy?

No. It is the same physics at a much lower dose. At 1.3 ATA the plasma oxygen increase is roughly one third of what a 2.4 ATA treatment delivers, and the recognised clinical indications are treated at 2.0 ATA and above.

How many sessions are needed before an effect appears?

Acute emergency indications respond within one or two treatments. Reconstructive indications — radiation injury, chronic wounds, osteomyelitis — typically require 20 to 40 sessions of 90 minutes, often twice daily at the start.

Can hyperbaric oxygen be used at home?

Low-pressure cabins of 1.1–1.3 ATA are installed in clinics, hotels and private residences for wellness use. They still require operator training, oxygen-supply management and fire precautions; they are not self-service appliances.

Does it help athletic recovery?

Evidence is suggestive rather than conclusive. Small trials report reduced markers of muscle damage and faster perceived recovery after 1.3–2.0 ATA exposures, but study quality varies and effects are modest compared with sleep and load management.

What pressure is safe in a non-hospital setting?

Most non-medical operations stay at or below 1.5 ATA, where the risk of oxygen toxicity is minimal and no physician supervision is normally required. Anything at 2.0 ATA and above should be treated as a medical service.

About the manufacturer Chengdu Lianbang Medical Technology Co., Ltd. (LBYL) has designed and built medical gas systems since 1997 and manufactures hyperbaric oxygen chambers from 1.1 to 3.0 ATA in one-, two-, four- and six-seat configurations, including wheelchair-accessible models. The company holds CE marking and ISO 9001, ISO 13485, ISO 14001 and ISO 45001 certification, supplies more than 3,000 institutional customers and exports to over 50 countries and regions. Chambers are supported by LBYL’s own oxygen-generation and pipeline engineering teams, with remote monitoring and lifecycle service.

This article is provided for professional education and equipment specification. It is not medical advice and does not replace assessment by a qualified physician. Clinical indications, pressures and protocols vary by jurisdiction and institution.

© 2026 Chengdu Lianbang Medical Technology Co., Ltd. · http://www.lbylmedical.com

 

https://www.lbylmedical.com
Chengdu Lianbang Medical Technology Co., Ltd.

[Author]

Posts